Professional Role and Experience
Keri Leone currently serves as the Senior Director, Global Medical Science & Education at Dexcom, Inc., a leading company specializing in continuous glucose monitoring (CGM) technology. She has over 15 years of experience in building, growing, and leading international commercial clinical and medical science teams within Dexcom. Her role prominently encompasses the leadership and development of global medical affairs and education initiatives focusing on CGM technologies.
Her LinkedIn profile and multiple conference listings confirm her responsibility for global medical science communications, as well as the implementation and educational outreach related to real-time continuous glucose monitoring (RT-CGM) applications particularly in pediatric and remote clinical settings. She is a frequent national and international speaker and subject matter expert on diabetes technology and the application of CGM devices in disease management.
Educational Background and Credentials
Keri Leone holds a Master’s Degree in Nutrition & Health Education and credentials including:
- MS (Master of Science)
- RD (Registered Dietitian)
- CDCES (Certified Diabetes Care and Education Specialist)
These qualifications provide her with a strong scientific foundation in both clinical nutrition and diabetes education, reinforcing her expertise in diabetes technology.
Areas of Expertise and Contributions
- Diabetes Technology and Patient Education: She specializes in evidence-based approaches to diabetes management through CGM technology, emphasizing patient empowerment and self-management.
- Pediatric Endocrinology and Behavioral Health: Her skill set extends to pediatric endocrinology and behavioral health integrations, focusing on real-time CGM in pediatric diabetes care, as demonstrated by her involvement in programs such as KDIGO and various Friends for Life diabetes conferences.
- Clinical Science Leadership: Oversees medical science teams supporting Dexcom’s CGM platforms, including legacy devices like the DexCom G4® Platinum Receiver and current innovation like the Dexcom G6® system.
- Research and Real-World Evidence: Actively involved in research demonstrating the clinical efficacy and health economic benefits of Dexcom’s CGM products for both Type 1 and Type 2 diabetes populations. Publications and abstracts associated with her demonstrate a focus on reductions in hypoglycemia, hospitalizations, diabetes-related medical costs, and improved glycemic control through CGM adoption.
Notable Professional Engagements and Presentations
- Speaker at the 56th annual meeting of the European Association for the Study of Diabetes (EASD), presenting on the implementation of RT-CGM in remote pediatric populations.
- Regular faculty member and contributor at Friends for Life conferences (2019-2021), a leading convention for diabetes clinicians, researchers, and patient advocates.
- Featured participant in DiabetesWise town halls and multiple educational forums addressing CGM technology during the COVID-19 pandemic, highlighting her role in patient education and advocacy.
- Contributor to multiple published abstracts, whitepapers, and clinical trial discussions illustrating CGM’s impact on hypoglycemia reduction and glycemic improvement supported by real-world evidence.
Publications and Intellectual Property
- Named inventor on patents related to data analytics and device algorithms for Dexcom’s CGM systems.
- Author/co-author in peer-reviewed clinical studies investigating the use of CGM in diverse diabetic populations, including studies on real-world glycemic control, healthcare utilization reduction, and behavioral interventions to improve diabetes self-management.
- Frequent presenter in scientific forums and panel discussions addressing the integration of digital health technology into diabetes care pathways.
Location and Contact Information
Based in San Diego, CA, Keri is strategically positioned within Dexcom’s headquarters region. Her LinkedIn profile is accessible at: [http://www.linkedin.com/in/keriweindel](http://www.linkedin.com/in/keriweindel).
Summary:
Keri Leone’s extensive leadership experience in global medical affairs at Dexcom, combined with her clinical expertise in diabetes education, nutrition, and pediatric endocrinology, make her a pivotal figure in advancing Dexcom’s CGM technologies. Her work centers on translating complex clinical science into accessible patient and provider education, supporting broader adoption of CGM devices, and generating evidence to establish real-world clinical and economic benefits. Her involvement in internationally respected conferences and research underscores her influence within both the medical and diabetes communities.
